Deciphera Employee Directory

Deciphera corporate office is located in 200 Smith St, Waltham, Massachusetts, 02451, United States and has 201-500 employees.

Likely to Engage tag.Highly Engaged Employees

Employees by Department

Departments

Number of employees

Medical & Health

90

Operations

89

Engineering & Technical

67

Information Technology

29

Sales

23

Legal

17

Finance

16

Deciphera CEO

RU
United States flag for contact location.
Ryota UdagawaPresident & Chief Executive Officer
PhonePhoneEmailEmail
See Profile

Key Employees of Deciphera

Deciphera Global Presence

globalPresence illustration
North America201-500
Europe11-50
Asia1-10

Index of contact profiles from Deciphera

Hundreds of professionals searching for Deciphera have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
12345

Former Employees at Deciphera

Explore people who held key positions, contributed to Deciphera's success, and advanced their careers.

People from Similar Companies in the Manufacturing Industry Located in Massachusetts, United States

Frequently Asked Questions Regarding Deciphera Employees

How many employees does Deciphera have?
Deciphera has 201-500 employees
Who is the CEO of Deciphera?
Deciphera’s CEO is Ryota Udagawa
Who are Deciphera key employees?
Some of Deciphera key employees are Annah Litzenberger, Matt Sherman, Masahiro Hamada
Where is Deciphera located?
Deciphera’s headquarters are located at 200 Smith St, Waltham, Massachusetts, 02451, United States
How do I contact Deciphera?
Deciphera Contact Info: Phone number: (781) 209-6400 Website: www.deciphera.com
What does Deciphera do?

Deciphera is a biopharmaceutical company focused on discovering, developing and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advan... cing multiple product candidates from our platform in clinical studies, QINLOCK® is Deciphera's FDA-approved switch-control kinase inhibitor for the treatment of fourth-line gastrointestinal stromal tumor (GIST). QINLOCK is also approved for fourth-line GIST in Australia, Canada, China, and Hong Kong.Read More

Is Deciphera a public company?
Deciphera is private company therefore does not currently have an official ticker symbol
See more information about Deciphera Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.